Genzyme Technique for Efficient Selection of Recombinant Cell-Lines
Do you want to know how to improve your cell line screening and selection to deliver the final product faster and cheaper? Would knowing how to address the following points help to strengthen your pipelines?
- Implementing high-throughput clone selection methods to reduce early stage development time by selecting the clones which are stable and express high titres
- Highlighting how new technologies and R&D methodologies can improve early stage development of therapeutic candidates
- Examine in closer detail the impact using a cell surface reporter can have on process efficiency by predicting relative expression levels of recombinant therapeutic proteins
Then you need to be at the Cell Culture World Congress taking place on the 28th, 29th February and 1st March, in Munich, where Dr Christine DeMaria, Senior Scientist, Therapeutic Protein Expression at Genzyme will be presenting strategies to achieve these goals!
Do you want to know more? click here